Rare disease detectives: new study maps how two genetic conditions unfold in children
NCT ID NCT05050669
First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time
Summary
This study follows children aged 2 to 18 with confirmed ENPP1 deficiency or early-onset ABCC6 deficiency to understand how these rare diseases progress. Researchers will measure blood markers, check for calcification in arteries and organs, and track bone health and movement over time. No treatment is given—the goal is to gather natural history data to inform future care and research.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors better understand how these rare diseases develop and change over time, potentially guiding future treatments.
- What could go wrong
- This is an observational study with no treatment being tested. It will not directly improve participants' health, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADENOSINE TRIPHOSPHATE BINDING CASSETTE TRANSPORTER PROTEIN SUBFAMILY C MEMBER 6 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Boston Children's Hospital
Boston, Massachusetts, 02115, United States
-
CHOP - Roberts Center for Pediatric Research
Philadelphia, Pennsylvania, 19146, United States
-
CHU Sainte-Justine
Montreal, Quebec, H3T 1C5, Canada
-
Cook Children's Hospital
Fort Worth, Texas, 76104, United States
-
Royal Manchester University Hospital
Manchester, Manchester, M13 9WL, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.